Reported 370,000 shares, unchanged from the prior quarter.
Reported value 256.3%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-12-31 | 819000 |
| 2026-03-31 | 1228500 |
| 2026-06-30 | 1539200 |
| 2026-09-30 | 5483400 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 370,000 | 0 (0.0%) | 0.91% | $5,483,400 | 2026-11-16 | |
| Q2 2026 | Added | 370,000 | +20,000 (5.7%) | 0.19% | $1,539,200 | 2026-08-14 | |
| Q1 2026 | Added | 350,000 | +50,000 (16.7%) | 0.18% | $1,228,500 | 2026-05-15 | |
| Q4 2025 | New | 300,000 | +300,000 (0.0%) | 0.13% | $819,000 | 2026-02-17 |
Who else reported the position
367 managers reported IOVANCE BIOTHERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 37,903,960 | +946,279 | < 0.01% | $561,736,688 | 9 qtrs |
| MHR FUND MANAGEMENT LLC | Unchanged | 28,967,103 | 0 | 21.06% | $429,292,466 | 16 qtrs |
| STATE STREET CORPORATION | Reduced | 21,695,003 | -2,783,265 | < 0.01% | $321,519,944 | 38 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 18,396,706 | +192,458 | < 0.01% | $272,639,183 | 3 qtrs |
| TWO SIGMA INVESTMENTS LP | Reduced | 14,964,996 | -4,045,701 | 0.16% | $221,781,241 | 10 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 12,279,882 | -2,109,117 | < 0.01% | $181,987,851 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 10,452,242 | +127,416 | < 0.01% | $154,930,479 | 38 qtrs |
| D E Shaw & Co Inc | Added | 9,163,428 | +7,020,294 | 0.06% | $135,802,003 | 28 qtrs |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 6,238,693 | -221,756 | 0.02% | $92,443,267 | 33 qtrs |
| The Goldman Sachs Group Inc | Reduced | 4,937,725 | -158,609 | < 0.01% | $73,177,091 | 38 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 370,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.